These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease. Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059 [TBL] [Abstract][Full Text] [Related]
7. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease. Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease. Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564 [TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease. Dafsari HS; Ray-Chaudhuri K; Ashkan K; Sachse L; Mahlstedt P; Silverdale M; Rizos A; Strack M; Jost ST; Reker P; Samuel M; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Timmermann L; J Neurol; 2020 Jun; 267(6):1830-1841. PubMed ID: 32152689 [TBL] [Abstract][Full Text] [Related]
10. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up. Jost ST; Sauerbier A; Visser-Vandewalle V; Ashkan K; Silverdale M; Evans J; Loehrer PA; Rizos A; Petry-Schmelzer JN; Reker P; Fink GR; Franklin J; Samuel M; Schnitzler A; Barbe MT; Antonini A; Martinez-Martin P; Timmermann L; Ray-Chaudhuri K; Dafsari HS; J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):687-694. PubMed ID: 32371534 [TBL] [Abstract][Full Text] [Related]
11. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study. Sobstyl M; Ząbek M; Górecki W; Mossakowski Z Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167 [TBL] [Abstract][Full Text] [Related]
12. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease. Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033 [TBL] [Abstract][Full Text] [Related]
13. Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age. Dafsari HS; Reker P; Stalinski L; Silverdale M; Rizos A; Ashkan K; Barbe MT; Fink GR; Evans J; Steffen J; Samuel M; Dembek TA; Visser-Vandewalle V; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Timmermann L; Mov Disord; 2018 Jan; 33(1):99-107. PubMed ID: 29150860 [TBL] [Abstract][Full Text] [Related]
14. Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder. Bargiotas P; Debove I; Bargiotas I; Lachenmayer ML; Ntafouli M; Vayatis N; Schüpbach MW; Krack P; Bassetti CL J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1310-1316. PubMed ID: 31422368 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease. Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947 [TBL] [Abstract][Full Text] [Related]
17. Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease. Dafsari HS; Weiß L; Silverdale M; Rizos A; Reddy P; Ashkan K; Evans J; Reker P; Petry-Schmelzer JN; Samuel M; Visser-Vandewalle V; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L; Brain Stimul; 2018; 11(4):867-874. PubMed ID: 29655587 [TBL] [Abstract][Full Text] [Related]
18. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease. Martinez-Fernandez R; Pelissier P; Quesada JL; Klinger H; Lhommée E; Schmitt E; Fraix V; Chabardes S; Mertens P; Castrioto A; Kistner A; Broussolle E; Pollak P; Thobois S; Krack P J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):311-8. PubMed ID: 25934016 [TBL] [Abstract][Full Text] [Related]
19. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years. Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710 [TBL] [Abstract][Full Text] [Related]